&nbsp;

Intent: Palliative

Funding:

New Drug Funding Program

Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

ZOLB(MNT)

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Drugs Used:

zolbetuximab

Quick Link(s):

Regimen Monograph

Nov 2025

Guidelines and Advice

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Status: Current
ID: GL 1-23-A

Jul 2021

Guidelines and Advice

Management of Ductal Carcinoma in Situ of the Breast

Status: Current
ID: GL1-10
Version: 4

Mar 2024

Regimen

MIRV

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

mirvetuximab soravtansine (Compassionate)

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

MTRX(5D)

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

methotrexate

Quick Link(s):

Regimen Monograph

Updated

Dec 2025

Regimen

MFOLFOX6+ENCO+CETU

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

cetuximab (Unfunded),

oxaliplatin,

leucovorin,

fluorouracil,

encorafenib (Unfunded)

Quick Link(s):

Regimen Monograph

New

Dec 2025

Regimen

MTRX

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

methotrexate,

leucovorin